Therefore, decreased MGMT activity, such as with reduced MGMT protein expression or methylation of MGMT, which is often observed in cancer cells, may increase the drug sensitivity and contribute to the antitumor properties of alkylating agents10. This evidence concerns the gene MGMT and cancer.